Percutaneous Neurostimulation in Knee Osteoarthritis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorTanta University
About this trial
Peripheral nerve stimulation (PNS) is a drug-free pain management procedure that uses electrical impulses to target specific nerves and block pain signals. PNS helps decrease perception of pain, providing real answers to patients dealing with chronic knee pain. The case study discussed in this presentation is of the use of PNS targeting the superior lateral genicular nerve and the saphenous nerve for a patient with moderate to severe knee pain from osteoarthritis
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
adults between the ages of 30 and 70 years with a clinical diagnosis of moderate to severe knee OA who suffered knee pain.
Patients who cannot afford intra-articular injections or radiofrequency ablation (RFA).
patients who had failed 2 different oral pain medications and 6 weeks of physical therapy.
Disqualifiers
Patients with OA show improvement in pain after physiotherapy.
patients evaluated by an orthopaedic surgeon and deemed to be surgical candidates due to knee pathologies other than OA.
pregnant patients.
patients on anticoagulation therapy, who were not permitted to stop anticoagulation.
Trial design
Design model
Parallel
Treatments tested in this trial
nerve stimulation using a nerve stimulator to the genicular nerve
Devicetemporary transcutaneous nerve stimulation using a nerve stimulator to the genicular nerve, with settings 2Hz, 0.2mA, 1ms, where the nerve is stimulated for 4 to 6 minutes.
nerve stimulation using a nerve stimulator to the saphenous nerve
Devicetemporary transcutaneous nerve stimulation using a nerve stimulator to the saphenous nerve, with settings 2Hz, 0.2mA, 1ms, where the nerve is stimulated for 4 to 6 minutes.
Treatment groups
100 Participants
are divided into 2 treatment groupsGroup A: transcutaneous nerve stimulation using a nerve stimulator to the genicular nerve blockExperimental treatment 1 intervention
Group B: transcutaneous nerve stimulation using a nerve stimulator to the saphenous nerveExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Change in visual analogue scale after intervention.
Decrement (clinical improvement) in visual analogue scale (VAS) immediately after intervention. The participant's knee discomfort was measured using a VAS. Participants were asked to score their level of pain on a 100-mm horizontal line, ranging from 0 to 100.
Time frame
immediately after intervention.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov